Study claim: A unique fermented blend of soy protein, yoghurt and honey supports weight reduction while preserving muscle mass and increasing energy and performance.
Published: Deibert P, et al. Weight loss without losing muscle mass in pre-obese and obese subjects induced by a high-soy-protein diet. Int J Obes Relat Metab Disord 2004 Oct; 28(10):1349-52.
Abstract: A randomised, controlled study included 90 participants exhibiting a body mass index (BMI) between 27.5 and 35. One group intervention consisted of lifestyle education, two other groups had a substitutional diet containing a high-soy-protein low-fat diet with (SD/PA-G) or without (SD-G) a guided physical activity program.
The diet was supplemented with soy-yoghurt/honey base Almased, which replaced two of the three meals per day for six weeks, then one meal for the subsequent 18 weeks. Subjects were measured for changes in body weight, fat mass and lean body mass at baseline, six weeks and six months.
In all, 83 subjects completed the six-month study. BMI dropped significantly in all groups. Lifestyle education: -2.2kg/m(2); SD-G: -3.1kg/m(2); SD/PA-G: -3.0kg/m(2).
Subjects in the SD-G and the SD/PA-G lost more weight (-8.9kg; 19.6lb) than did those in the lifestyle education group (-6.2kg; 13.6lb) — a 44 per cent difference — and had a greater decrease in fat mass (-8.8kg; 19.4lb, and -9.4kg; 20.7lb) than those in the lifestyle education group (-6.6kg; 14.5lb).
In contrast, no significant intra-individual or between-group changes in the fat-free mass were seen. In all groups, metabolic parameters showed an improvement in glycaemic control and lipid profile.
Potential applications: Sold in retail stores as a powder, Almased can be mixed with water, juice or milk and consumed as part of a high-protein, low-fat diet to improve body composition.
More info: Almased www.almased.com +1 800 256 2733
Study claim: The essential mineral chromium improves insulin function and glucose metabolism in people with type 2 diabetes and related conditions.
Published: Cefalu WT, Hu FB. Role of chromium in human health and in diabetes. Diabetes Care 2004 Nov; 27(11):2741-51.
Abstract: This published review of more than 40 studies on the essential mineral chromium provides the most current information on chromium?s mechanism of action and includes a literature review of clinical trials using chromium in patients with diabetes. Growing evidence suggests that chromium supplementation, particularly in the form of chromium picolinate, may improve insulin sensitivity by potentiating the action of insulin to stimulate glucose transport into cells. This suggests that supplementation with chromium picolinate can improve insulin function and glucose metabolism in people with type 2 diabetes and related conditions, such as obesity and heart disease.
In addition, results from controlled clinical trials have shown that treatment with chromium at doses up to 1,000mcg/day and for periods as long as 64 months does not result in any toxic effects. These data add to the large body of evidence showing that chromium picolinate is safe, and, specifically, that there are no effects on liver and kidney function, which is of particular importance to people with diabetes. Complications of poor blood glucose control in people with type 2 diabetes include heart disease and stroke, blindness, kidney damage and amputation.
Potential applications: Chromax is GRAS for use in nutritional bars and beverages as a nutrient supplement, at a maximum use level of 2.4mcg Chromax per product serving.
+1 914 701 4500